Evidence map›Paper›PMID 32100402›Full record

ReviewCell proliferation2020

Ferroptosis: Final destination for cancer?

Zeng Ye, Wensheng Liu, Qifeng Zhuo, Qiangsheng Hu, Mengqi Liu, Qiqing Sun, Zheng Zhang, Guixiong Fan, Wenyan Xu, Shunrong Ji and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Cell proliferation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. The mechanism of Akkermansia muciniphila inhibiting the proliferation of colorectal cancer cells via ferroptosis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Targeting ferroptosis for precision medicine in cervical cancer.Apoptosis : an international journal on programmed cell death · 2025
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Zeng YeDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Wensheng LiuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Qifeng ZhuoDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Qiangsheng HuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Mengqi LiuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Qiqing SunDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Zheng ZhangDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Guixiong FanDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Wenyan XuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Shunrong JiDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Xianjun YuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID https://orcid.org/0000-0002-6697-7143
Yi QinDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Xiaowu XuDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.ORCID https://orcid.org/0000-0001-5792-9839
Shanghai Medical College of Fudan University · CN

Funding

National Natural Science Foundation of China 81602085National Natural Science Foundation of China 81702871National Natural Science Foundation of China 81871950
6 · The paper itself

Abstract

Ferroptosis is a recently defined, non-apoptotic, regulated cell death (RCD) process that comprises abnormal metabolism of cellular lipid oxides catalysed by iron ions or iron-containing enzymes. In this process, a variety of inducers destroy the cell redox balance and produce a large number of lipid peroxidation products, eventually triggering cell death. However, in terms of morphology, biochemistry and genetics, ferroptosis is quite different from apoptosis, necrosis, autophagy-dependent cell death and other RCD processes. A growing number of studies suggest that the relationship between ferroptosis and cancer is extremely complicated and that ferroptosis promises to be a novel approach for the cancer treatment. This article primarily focuses on the mechanism of ferroptosis and discusses the potential application of ferroptosis in cancer therapy.

Indexed as

FerroptosisLipid PeroxidationAnimalsGlutathioneHumansIronNeoplasmsPeroxidesPhospholipid Hydroperoxide Glutathione PeroxidaseProto-Oncogene Proteins p21(ras)Tumor Suppressor Protein p53GlutathioneIronPeroxidesPhospholipid Hydroperoxide Glutathione PeroxidaseProto-Oncogene Proteins p21(ras)Tumor Suppressor Protein p53cancer therapyferroptosisGPx4lipid peroxidation

Identifiers

PMID32100402
PMCPMC7106955
OpenAlexW3008578108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.